Bumper Offer - Urjas oil Just @ Rs. 1
Moxitobra is an allopathic medicine The correct dosage of Moxitobra depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Moxitobra is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Moxitobra is used -
Severe
Moderate
Mild
Common
Is the use of Moxitobra safe for pregnant women?
Moxitobra should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Moxitobra safe during breastfeeding?
Moxitobra may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Moxitobra, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Moxitobra.
What is the effect of Moxitobra on the Kidneys?
Moxitobra rarely harms the kidneys.
What is the effect of Moxitobra on the Liver?
Moxitobra is not harmful for the liver.
What is the effect of Moxitobra on the Heart?
You can take Moxitobra without any fear of damage to the heart.
Moxitobra should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Moxitobra unless your doctor advises you to do so -
Is this Moxitobra habit forming or addictive?
No, you will not get addicted to Moxitobra.
Is it safe to drive or operate heavy machinery when consuming?
Moxitobra does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Moxitobra only as per medical advice.
Is it able to treat mental disorders?
No, Moxitobra cannot treat any kind of mental disorder.
Interaction between Food and Moxitobra
Taking Moxitobra with food is safe.
Interaction between Alcohol and Moxitobra
Information about the interaction of Moxitobra and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tobramycin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-141
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tobramycin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-141